Kiniksa Pharmaceuticals, Ltd.

Q2 2026 13F Holders

Symbol
KNSA
CUSIP
G52694109
Type
Equity
Class
ORD SHS CL A
Num filings
279
Total reported value, excl. options
$3.04 B
Manager Report Date Value ($000) Shares Option Type